LAUREN WINTERS: Open Payments
NPI 1821716424 · IOWA COLONY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 19 payments from 8 companies in 2025. Trend: 2023 $430 · 2024 $544 · 2025 $982
Food & beverage: $982
| Company | Payments | Amount |
|---|---|---|
| One Lambda, Inc. | 1 | $380 |
| Veloxis Pharmaceuticals, Inc. | 8 | $205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $165 |
| Novo Nordisk Inc | 1 | $102 |
| ABBVIE INC. | 3 | $47 |
| Baxter Healthcare | 1 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: ENVARSUS, LIVTENCITY, Rivfloza, TEFLARO, PERCLOT, XIFAXAN, PREVYMIS.
Industry payments across TX — which companies pay providers there.
